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Although their mechanisms of action are unclear, a number 
of growth factors h.as been S~OWI~ to promot~ cut~neous 
wound repair. Keratll10cyte migration and proltferatlon are 
required for re-epithelialization, and there is evidence to 
suggest that these processes may be regulated by one or more 
growth .factors tha~ promote wound repair. .using t.he pha-
gokinetlc assay, wluch allows direct observation of migration 
path as a gold-particle - free area, we examined the effects of 
epidermal growth factor (EGF) and insulin-like growth fac-
tor I (IGF-I) on human keratinocyte migration. Addition of 
EGF to defined medium in the absence of any other growth 
factor induced an increase in migration of 2.5 - 4.5 fold after 
overnight incubation; the e~ect of E~F on migration was 
concentration dependent, with a maximum at 10 to 50 ng/ 
M igration of keratinocytes from the wound edge and their subsequent proliferation are essential for cutaneous wound repair [1-4]. The wound site is rich in growth factors, and it is very likely that coordinated action by several of these factors is 
required for a normal epit~elial response to injury [5,6]. In vivo, 
acceleration of wound repair has been observed followmg. topical 
application of a number of growth factors, ll1cludmg epidermal 
growth f~ctor (EGF) [7,8], transforming growth factor~a (TGF-a) 
[9] insubn-ltke growth factor I (IGF-I) [6], and baSIC fibroblast 
gr~wth factor [10]. Each of these factors is known to promote kerati-
nocyte proliferation in vitro [11-14]; h~wever, their effects on kerat-
inocyte rn.igration are not clearl~ establtshed, and m the case ofEGF, 
conflicting data have been publtshed [14-16]. 
In the present study, we evaluated the effects of EGF, TGF-a, 
IGF-I, and insulin on human keratinocyte migration using the P~1a­
gokinetic assay, which measures pure, random cell locomotion 
[17-20]. In this assay method, c.ells are plated on collOl~al gold 
particles that have been co~ted ':Ith an extracellular matnx mole-
cule. Migration tracks of mdlvldual cells are easIly and directly 
visualized because the cells phagocytize and/or displace gold partl-
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Abbreviations: 
BPE: bovine pituitary extract 
BSA: bovine serum albumin 
EGF: epidermal growth factor 
HBSS: Hanks' balanced salt solution 
19: immunoglobulin 
IGF-I: insulin-like growth factor I 
TGF-a: transforming growth factor-a 
ml EGF. Concentration-dependent enhancement of kerati-
nocyte migration was similarly observed with IGF-I as well 
as insulin. With all factors, migration was observed on col-
loidal gold plates coated with collagen IV or with fibronectin 
but not in the absence of matrix coating. To examine further 
the involvement of the EGF receptor in keratinocyte migra-
tion, we tested the effect of a monoclonal antibody to the 
EGF receptor that acts as an antagonist. EGF-induced migra-
tion was completely prevented by this antibody; however, 
the enhancement by insulin or IGF-I was not blocked. These 
results suggest that IGF-I and insulin enhance keratinocyte 
migration by a mechanism distinct from that ofEGF.] Invest 
DermatoI100:633-639, 1993 
cles during movement. This assay does not depend on an experimen-
tally established chemotactic gradient, and it is not complicated by 
concurrent cell division [17 - 20]. Our results indicate that several 
growth factors with relevance for iI, lIivo wound repair increase 
keratinocyte migration. 
MATERIALS AND METHODS 
Materials MCDB 153 base powder and all of the medium supple-
ments (except EGF and antibiotics) were purchased from Sigma 
Chemical Co. (St. Louis, MO). Mouse EGF and human recombi-
nant basic fibroblast growth factor were obtained from Collabora-
tive Research (Bedford, MA). Human recombinant EGF was from 
Boehringer Mannheim Corp. (Indianapolis, IN) . Human recombi-
nant TGF-a, IGF-I, and penicillin/streptomycin solution were 
from Gibco Laboratories (Grand Island, NY). Pepsinized human 
placental type IV collagen and human plasma fibronectin were from 
Sigma and Boehringer Mannheim, respectively. Mouse monoclonal 
antibody against human EGF receptor (425) [21 ,22] was a kind gift 
from Dr. Ulrich Rodeck (Wistar Institute, Philadelphia, PA), and 
normal mouse immunoglobulin (lg)G was purchased from Chemi-
con (Temecula, CA). Bovine serum albumin (BSA) (A-4161), fatty 
acid-free BSA (A-0281), and ovalbumin (A-5503) were from 
Sigma. Heat-denatured BSA was prepared by heating a 1 % solution 
in Hanks' balanced salt solution (HBSS) at 80°C for 3 min. Gold 
chloride (HAuCI4) was obtained from J.T. Baker (Phillipsburg, 
NJ). Bovine pituitaries were obtained from Pel-Freez (Rogers, AR) 
and were extracted as previously described [23]; bovine pituitary 
extract (BPE) was stored at - 20 ° C. 
Cell Culture and Medinnl Human keratinocytes from neonatal 
foreskin were propagated in MCDB 153 base medium with 30,uM 
Ca++ and the following additives: BPE (140 ,ug/ml), insulin (5 
,ug/ml), mouse EGF (10 ng/ml), hydrocortisone (0.5 ,uM), ethanol-
amine (0.1 mM), phosphoethanolamine (0.1 mM), high amino 
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(um2/ccll X 10- 3) 
0.90 ± 0.16 
1.77 ± 0.22 
2.99 ± 0.31 
3.63 ± 0.31 
1.93 ± 0.07 
1.97±0.14 
4.45 ± 0.29 
4.74 ± 0.45 
4.80 ± 0.23 
1.74 ± 0.07 
4.15 ± 0.26 
4.52 ± 0.57 
5.04 ± 0.74 
4.69 ± 0.59 
5.55 ± 0.31 
5.89 ± 0.76 
Mi gration Index 
(% of area) 
1.12 ± 0.24 
2.22 ± 0.28 
3.60 ± 0.40 
3.97 ± 0.56 
2.24 ± 0.16 
2.49 ± 0.13 
6.08 ± 0.20 
6.70 ± 0.61 
6.65 ± 0.33 
2.36 ± 0.13 
5.71 ± 0.49 
6.04 ± 1.17 
6.80 ± 0.76 
6.71 ± 1.59 
7.46 ± 0.65 
7.98 ± 1.34 
'Human keratinocytes were plated on colloidal go ld - and type IV collagen-coated plates and incubated for 21 h (experiment 1) or 22 h (experiments 2 and 3). Cell migration was 
quantified by image analysis and ex pressed as average migration [20] and migration index [1 6,19]. 
b Different batches of BPE were used for experiments 2 and 3. 
acids, 100 IU /ml penici llin, and 100 Ilg/ml streptomycin, as previ-
ously described [24]; this medium is referred to as complete MCDB 
medium. MCDB(-) medium refers to the MCDB 153 base me-
dium supplemented with ethanolamine, phosphoethanolamine, 
h igh ami no acids, penici llin, and streptomycin, but without growth 
factors. 
Cell Viability To assess cell viabi li ty, keratinocytes were plated 
on type IV collagen-coated plates at 1000 cells/cm2 in MCDB(- ) or 
complete MCDB medium. After overnight incubation, cells were 
98 - 99% viable by trypan blue exclusion tests. 
Preparation of Colloidal Gold-Coated Plates Gold-coated 
rlates were made accord ing to th e method of Albrecht-Bueh ler 17], with a slight modification (i .e. , multiwell plastic plates that 
had not bee n treated for tissue culture were used instead of glass 
coverslips). Non-treated plates consistently supported better migra-
Figure 1. Effect ofEGF on keratinocyte mi-
gration. Plastic 12-well plates were coated 
with colloidal gold and type IV collagen (10 
fig/well). Human foreskin keratinocytes 
were seeded on the coated plate at 3600 cells/ 
well and incubated in MCDE(-) medium 
containing 20 Jig/ml ESA without EGF (A) 
or in the presence of EGF at the following 
concentrations: (B) 0.5 ng/ml, (C) 5.0 ng/ 
ml, (D) 50.0 ng/m l. After 20 h of incubation 
at 37" C, ce lls were fixed in 3% formaldehyde 
and photographed under dark-field optics. 
Dark regiolls on the bright background corre-
spond to the area of migration (phagokinetic 
tracks). The average migration quantified by 
image analysis for each panel is (A) 1.9 X 103 
Jim2/ce ll , (B) 3.9 X 103 fim2/cell , (C) 
4.8 X 103 Jim2/cell , and (D) 5.6 X 103 fim2/ 
cel l. Ba r, 500 Jim. . 
tion than tissue culture - treated plates. Non-treated 12-well cluster 
p lates (Costar, Cambridge, MA) were first incubated for 5 min at 
room temperature with 1 % BSA in water. After aspiration, the wells 
were rinsed with 100% ethanol and dried in the hot airstream of a 
hair dryer. In some experiments, fa try acid - free BSA was used for 
this coating step; resu lts were the same regardless of BSA prepara-
tion used. For the next step, coll oidal gold suspension was prepared 
by mixing 1.2 ml of 14.5 mM gold ch loride, 4 ml of 36.5 rnM 
sodium carbonate, and 7.3 ml of water; this volume was sufficient 
for one plate. The solution was heated to boiling, at wh ich time 
1.2 ml of 0.1 % forma ldehyde was added. While still hot (65-
75 DC), 1 ml of the colloidal go ld solu tion was placed in each well. 
After 20 min of incubation at room temperature, the wells were 
washed twice w ith HBSS. Fina ll y, the colloidal gold-coated wells 
were incubated for 60 min at room temperature in 0.5 m l HBSS 
containing type IV collagen (1-100 Ilg/well) or fibronectin (1-20 
h ~ 
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Figure 2_. Quantihcati?n of keratinocyte migration induced by. EGF. As 
described In Fig 1. keratll10cytes were ll1cubated on wel ls coated with collOI-
dal gold and type IV collagen in medium containing the indicated concen-
rrations of EGF. The migration area was measured by image analysis. For 
each point. the migration area per cell was determined in three fields. which 
were then averaged. and the SO of the three values was determined. The data 
are expressed as migration area per cel l ± so (illllm2). The results of three 
experiments with keratillocytes from different donors are shown. 
fLg/well). After incubation. th e supernatant was aspirated. and 
0.4 ml of MCDB(-) medium with growth factors, as indicated in 
the individual experiments, was added to each wel l. 
Migration Assay Cells were harvested from 50-80% confluent 
human foreskin keratinocyte cultures between passages 2 and 4 by 
0.2% t rypsi n/ ethylenediaminetetraacetic acid treatment. Trypsin 
was neutralized with 0.1 % soybean trypsin inhibitor in HBSS, and 
the cell suspension was centrifuged. Cells were then suspended in 
MCDB(-) medium with 20 ,ug/mIBSA at 9 X 103 cells/ml ; 0.4 ml 
of the c e ll suspension was added to each well. which already con-
tained 0.4 ml of medium and, when indicated, appropriate growth 
factors to be tested. The fin al concentration of cells plated was 
1000/ cm2. The cell s were incubated on colloidal gold-coated 
plates for 2-23 h at 3rc in a humidified incubator with 5% car-
bon dioxide. At th e end of the incubation, the cell s were fixed with 
3% formaldehyde in phosphate-buffered saline and observed under 
dark-field illumination. 
To quantify cel l migration, we calculated migration area per cell 
(in squ are micrometers), as described previously by Guo et al [20]. 
Specifically, three fields pe~ well were photographed, and the area 
of displaced gold was outlll1ed around 30 cells. The total area of 
migration by these cells was measured using an image analyzer 
(south ern Micro Instruments, Atlanta, GA), and then the mi gration 
area per cell was calculated for each field . Finally, the migration 
areas per cell in each of the three replicate fields were averaged, and 
the standard deviation of the three values was calculated. In Table I 
data are expressed in two ways: as average migration per cell and as 
migration index [16 ,19]. Migration index is defined as the percent 
of cotal field area taken up by migration tracks and was calculated as 
described previously by Sarret et al [1 6]. 
RESULTS 
EGF Effect on Migration The effect of EGF on human kerati-
nocyt e migration was measured by the phagokinetic assay . In the 
control wells incubated without any growth factors, the immediate 
pericellular area was consistently cleared of gold particles, creating a 
small halo around the cells; in addition, some short tracks were 
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observed (Fig 1A) Addition of human recombinant EGF caused a 
stimulation of migration in a concentration-dependent manner, vi-
sualized by elongation of the migration trac ks or enlargement of the 
halos around the cel ls (Fig I B-D) . 
The enhancement ofkeratinocyte migration by EGF was quanti-
fi ed by image analysis; the results wi th cultures fro m three different 
donors are shown in Fig 2. Although the absolute extent of migra-
tion varied from culture to culture, EGF enhanced the mi gration of 
every keratinocyte culture studied (more than 10 cultures). In dif-
ferent experiments, the maximal enhancement ranged from 2.5 to 
4.5 fo ld in the presence of EGF compared with the base migration 
observed in the absence of exogenous growth factors. Maximal en-
hancement was reached at a concentration between 10 and 50 ng/ 
ml of EGF (Fig 2) and was similar to that obtained in complete 
MCDB medium (Fig 4). H alf-maxima l en hancement of migration 
was observed at 0.3 - 2.0 ng/ ml EGF. The total number of cells 
ad herent to the plate was very similar in the presence or absence of 
EGF (Figs 1 and 3). Enhancement of migration was not specific to 
human recombinant EGF but was also observed with mouse EGF 
and human TGF-a, which also activates the EGF receptor. 
To detect optimal, consistent stimulation of migration by EGF, 
supplementation of the base medium with carrier protein was re-
quired . Although an effect of EGF was observed in some experi-
ments in the absence of carrier protein, in most cases the addition of 
EGF to medium w ithout any carrier protein resulted in rather poor 
enhancement of migration (Fig 3A,D). Several different carrier pro-
teins were tested, i.e., native BSA (Figs 1 and 2), fatty acid - free 
BSA, heat-denaturedBSA (Fig 3B,E), and ovalbumin (Fig 3C,F); all 
of these led to consistent restoration of EGF-induced migration. 
Carrier protein alone (i .e., w ithout EGF) had only a minimal effect 
on migration (Fig 3A - C ). These results indicate that the effect of 
carrier protein is non-specific. 
Matrix Molecule Effects The experiments described above 
were all performed usi ng coll oidal gold plates that had been coated 
with type IV collagen. In agreement with previous reports [18 -20], 
we found that coating the coll oida l gold w ith an extracellular ma-
trix molecule was required for keratinocyte migration. Further-
more, the extent of mi gration was dependent on the amount of 
matrix molecu le used for coating (Fig 4). With type IV co ll agen, 
increased migration was observed when the coating amount was 
111creased from 1 to 20 ,ug/well (Fig 4); a further increase in migra-
tion was not generated by increasing the coll agen to 100 ,ug/well 
(data not shown). Fibronectin also supported keratinocyte migra-
tion, although the extent of migration was never as great as on type 
IV collagen. Maximal migration was observed at 5 - 10 Ilg/well of 
fibronect111 (FI~ 4); hi gher amounts of fibronectin (20,ug/well) led 
to a decrease 111 the extent of migration (data not shown). EGF 
stimulation of migration was observed on both fibronectin- and 
type IV coll agen-coated colloida l go ld plates at all matrix concen-
trations examined (Fig 4). 
N ot .a ll e.xtracellul ~ r matrix molecul es would support keratino-
cyte 111lgratlon. Consistent With previous studies [1 9], laminin coat-
ing did not lead to keratinocyte migration , even in the presence of 
EGF or complete medlllm (data not show n) . Coating the colloidal 
go ld plate with BSA also did not support migration [19]. 
Time Course and Effect of Cycloheximide T he time course 
of keratinocyte mi gration on type IV co llage n was determined in 
the presence and absence ofEGF and cyclohex imide (Fig 5). Within 
1 h of plating, cell attachment and the format ion of small halos 
around the cells were similarly observed in the presence or absence 
of EGF and/ or cycloheximide. In the absence of cycloheximide, 
enhancement of migration by EGF was detectable by 2 h after plat-
ing and increased for several hours thereafter. Addition of cyclo-
heximide (5 Jlg/ ml) resulted in the inh ibition of migration in the 
presence or absence of EG F, indicating that protein synthesis is 
required for keratinocyte migration under our assay conditions. The 
inhibitory effect of cycloheximide on cell migration was not a result 
of its cytotoxicity because removal of cycloheximide after 5 h of 
incubation allowed restoration of migration (Fig 5). 
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Figure 3. Effect of EGF on keratinocyte migration in the presence and absence of carrier proteins. Keratinocytes were seeded on type IV collagen-coated 
colloidal gold well s, as described in Fig 1 but in the fo llowing media: (A,D) MCDB(-); (B,E) MCDB(-) containin g 20 J.lg/ml heat-denatured BSA; (C,F) 
MCDB(-) containing 20 J.lg/ml ovalbumin in the presence (D - F) or absence (A - C) of 10 ng/ ml EGF. Incubation was carried out for 22 h at 37°C. The 
average migration quantified by image ana lysis for each panel is (A) 0.9 X 103 J.lm2/ce ll , (B) 1.5 X 103 J.lm2/cell, (C) 1.4 X 103 J.lm2/ce ll , (D) 2.2 X 103 
J.lm2/ce ll , (E) 4.7 X 103 J.lm2 cell , and (F) 4.4 X 103 J.lm 2/ cell. Bar, 500 J.lm. 
Insulin/IGF-I Effect on Migration Both insulin and IGF-I en-
hance kerafinocyte proliferation through activation of the IGF-I 
receptor [13]. As shown in Figs 6 and 7A -C, a large enhancement 
of migration, comparable in magnitude to that obtained with EGF, 
was observed in the presence of insulin or IGF-1. The effect of 
insulin or IGF-I was concentration dependent (Fig 6), but the con-. 
centration of IGF-I required for enhancement was much less than 
the required concentration of insulin . This result was expected be-
cause the affinity of IGF-I for its receptor is much greater than that 
6 
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Figure 4. Substratum protein requirement for keratinocyte migration. Ker-
atinocytes were seeded on colloidal gold coated with no protein, type IV 
collagen (Col) at 1 or 20 J.lg/well, or fibronectin (FN) at 5 J.lg/well. Cells 
were incubated for 20 h at 37"C in MCDB(-) containing 20 J.lg/ml BSA 
(opell bars); MCDB(-) containing BSA and 50 ng/ml EGF (diagollally 
stripped bars), or complete MCDB medium (checkered bars). The area of cell 
migration was quanitifed by image analysis and expressed as in Fig 2. The 
asterisk denotes a statistically significant (Student t test, p < 0.01) effect of 
EGF or complete medium compared with control medium without growth 
factors. 
of insulin [25]. The time course of insulin-induced migration was 
simi lar to that of EGF enhancement (data not shown). 
Other Factors and Combinations of Factors The mitogenic 
activity of insulin or EGF on human keratinocytes is well known. 
However, in agreement with previous investigators [16,26,27], we 
found that the abi lity to enhance proliferation was not always corre-
lated with the abi lity to enhance migration. Basic fibroblast growth 
factor, which enhanced proliferation to the same extent as EGF 
[26,27]' had no effect on keratinocyte migration in the phagokinetic 
assay (data not shown), as previously reported [1 6]. 
To permit more direct comparison of our work with published 
experiments [1 6]. we examined the effect ofEGF in the presence of 
the other supplements added to routil~e serum-free keratinocyte 
culture media, i.e. , insulin, EPE, and hydrocortisone. In addition, 
we expressed the data from several experiments (Table I) as both 
average migration per cell and migration index. Hydrocortisone 
was found to have no effect on migration when added alone or in 
combination with insulin, EPE, and/or EGF (data not shown) . In-
sulin at 5 J.lg/ml enhanced migration; addition ofEGF plus insulin 
led to further enhancement (Table I, experiment 1) . 
Our examination of the effect ofEPE on migration revealed great 
variation from batch to batch. Some preparations induced excellent 
migration, whereas others led to no change above background 
(Table I; compare experiments 2 and 3). Although we do not under-
stand the specific reason for this variability, it is most likely related 
to the fact that EPE is a crude, unpurified homogenate [23]. It is 
important to note that both of the batches of EPE shown in Table I 
supported routine keratinocyte culture initiation and proliferation 
in complete medium with equal vigor, even though their effects on 
migration were so dramatically different. EGF and insulin induced 
cell migration in the presence of EPE; however, the effects of EGF 
and insulin were much more apparent when the added EPE batch 
itself had low to negligible stimulatory ac tivity (experiment 2, 
Table I) . 
EGF Receptor Involvement To investigate the involvement of 
the EGF receptor in the enhancement ofkeratinocyte migration by 
growth factors, we used an anti-EGF receJ?tor monoclonal anti-
body (425) that acts as an antagonist [21,22J. This antibody com-
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Figure 5. Time course and effect of cycloheximide on keratinocyte migra· 
tion. As described in Fig 1, keratinocytes were seeded on colloidal gold plates 
coated w ith type IV collagen and incubated in the presence (closed symbols) or 
absence (open symbols) of 5 Jlg/ml cycloheximide in MCDB(-) containing 
20 Ilg/m1 BSA (circles) and MCDB(-) containing BSA and 10 ng/ml EGF 
(lq tlares). The closed triartgle shows the migration of ce lls that had been 
incubated with EGF and cyclohex1I111de for 5 h, at wll1ch tIIne ce lls were 
washed and further incubated in the presence ofEGF but no cycloheximide 
for 18 h. The migration area was analyzed and expressed as described in 
Fig 2. 
petes with EGF for binding to the receptor, but it does not activate 
the receptor. The addition of a molar excess of this anti -EGF re-
ceptor antibody completely prevented the 1I1crease 111 cell migration 
induced by exogenous EGF (Fig 7B,E ). Quantification by image 
analysis revea led tha.t the anti -EGF receptor antibody decreased 
EGF-induced migratIOn to basal level. Control mouse IgG had no 
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Figure 6. Effect of IGF·I on keratinocyte migration. Keratinocytes were 
!Uded on co lloidal gold plates coated with type IV collagen 111 MCDB(-) 
medium containing 20 Jlg/ml BSA and various amounts of IGF·I, as indi-
ared. In some wells. anti -EGF receptor monoclonal antibody 425 (10 
fig/ml) was added . Incubation was ca.rried out for 21 h at 3~oC. The migra-
tion area was analyzed and expressed as descnbed III FIg 2. Student t test 
analysis showed no significant difference between 20 ng/ml IGF-I in the 
presence and abse nce of anti-EGF receptor antibody. Addition of control 
mouse IgG had no effect on migration. 
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increase in keratinocyte migration was mediated via the EGF re-
ceptor. 
In contrast, the antagonist anti -EGF receptor antibody did not 
inhibit migration induced by insulin or IGF-I (Figs 6 and 7C,F) . 
These results show that the stimu latory effect of insulin or IGF-I on 
migration was not mediated throu gh the EGF receptor. 
DISCUSSION 
In the present study. we demonstrated that EGF, IGF-I, and insulin 
increase human keratinocyte locomotion, as measured by the pha-
go kinetic assay [17 -20] in chemically defined medium. T he en-
hancement is dependent on matrix molecule. N on-coated colloidal 
gold particles do not support migration in the presence or absence of 
growth factors; neither does coating with BSA or laminin; however, 
type IV collagen and fibronectin both support migration induced by 
EGF, IGF-I, or insulin. These data are consistent w ith previous 
reports concerning th e effects of different matrix molecules on ke-
ratinocyte migration [1 8-20] . Migration induced by EGF, but not 
by insulin/ IGF-I, is blocked by inclusion of an antagonist monoclo-
nal antibody to the EGF receptor. These results strongly implicate 
specific engagement of th e EGF receptor as an activation pathway 
for keratinocyte migration; furthermore. they suggest that migra-
tion can also be ac tivated independently of the EGF receptor, i.e., 
via the I G F-I receptor. 
Enhancing effects of EGF and insulin/ IGF-I on epithelial cell 
migration in a number of experimental systems have been reported. 
Insulin stimulates newt epithelial outgrowth in an explant system 
[28]. In modified Boyden chamber assays, IGF-I has chemotactic 
activity for bovine bronchial epithelial cells [29] and human retinal 
pigment epithelial cell s [30]. EGF has been found to increase epithe-
lial cell migration in several studies: 1) EGF and TGF-a permit the 
expansion through migration of human keratinocyte colonies [1 4]; 
2) pre-treatment with EGF promotes human keratinocyte motil ity 
in a micropore filter assay [1 5]; 3) EGF is chemotactic for rat intes-
tinal epithelial cel ls [31 ]; 4) in the presence of insulin, EGF increases 
rat liver epithelial cell moti lity, as analyzed by stainin g for secreted 
matrix protein [32]; and 5) EGF stimulates epidermal ou tgrowth in 
porcine skin explant cu lture [33]. 
In contrast, in a recent study using the phagokinetic assay, murine 
EGF is reported to have no effect on human keratinocyte locomo-
tion [1 6]. The reasons for the discrepancy between this study and 
our findings are not clear, but species selectivity is not likely to be a 
factor. Most of our data were generated with human recombinant 
EGF, but we also found similar results with murine submaxillary 
EGF. One possib le explanation concerns differences in the compo-
sition of the media used for migration assays in the two studies. We 
routinely include carrier protein in all media because prel iminary 
experiments showed that it is required for consistent, optimal en-
hancement of mi gration by growth factors. Carrier protein alone 
does not promote appreciable migration. The growth factors, partic-
ularly EGF and IGF-I, are used at very low concentrations (nano-
grams per mi lliliter); hence, non-specific loss of these proteins on 
test-tube walls, culture dishes, or the colloidal gold beads may de-
crease the effective concentration ava ilable to the keratinocytes. 
Carrier protein may exert its effect by preventing non-specific loss 
of growth factors durin g the experimental manipulations and incu-
bations. 
Another difference betwee n the resul ts of Sarrett et af [1 6J and our 
present findin gs is the absolute extent of migration in complete 
medium. In the form er study [1 6]. a maxima l migration index of 
25 - 30% was reported. In our study, we observed a considerably 
smaller maximal migration. We found a maximal migration mdex 
of 5 - 8% and an average migration of 4-6 X 103 ,Llm2/celJ. These 
values for maximal mi gration were consistent throughout the 
course of the study. Previous reports were variable. with some 
showing hi gh maximal migration indices [1 9J and others [20,34] 
showing a lower maximal migration. which is si~il ar to our iJresent 
report . W e do not know the reason for this difference. b~t It sug-
gests unknown variables in the manipulations of keraunocytes, 
assay plates, etc., that might also influence the response to growth 
factors. 
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EGF Insulin 
Figure 7. Differential effects of anti-EGF receptor monoclonal antibody on EGF- and insulin-induced migration of keratinocytes. Keratinocytes were 
seeded on type IV collagen-coated colloidal gold wells, as described in Fig 1 but in the following media: (A,D) MCDB(-) with 20 Jig/ml BSA; (B,E) 
MCDB(-) with BSA and 10 ng/ml EGF; (C,F) MCDB(- ) with BSA and 5 Jig/ml insulin in the presence of 10 Jig/ml normal mouse IgG (A-C) or 
monoclonal antibody 425 against the EGF receptor (D-F). Average migration values are (A) 1.3 X 10' Jim2/ce ll , (B) 4.5 X 10' Jim2/cell, (C) 4.0 X HP 
Jim2/ cell, (D) 1.4 X 10' Jim2/ cell, (E) 1.5 X 10' Jim2/ cell, and (F) 4.1 X 10' Jim2/ cell. Bar, 500 Jim. Similar results were obtained at a higher concentration 
of antibodies (25 Jig/ml). 
The mechanism by which EGF or insulin/IGF-I enhances kerati-
nocyte migration is unknown, although several recent studies imply 
that the factors might modulate keratinocyte interaction with their 
extracellular matrix. EGF and insulin/IGF-I are known to stimulate 
production of matrix proteins in keratinocytes [12,15] , and EGF has 
been shown to induce P1 integrin expression in fibroblasts [35] . A 
recent publication has provided evidence that p1 integrin in associa-
tion with as and a2 is necessary for keratinocyte migration on 
fibronectin and type IV collagen, respectively [36] . Kim et at [36] 
also suggest that modification of the matrix by keratinocytes may 
influence the extent of migration both ill vitro and ill vivo. In addi-
tion, studies showing linkage of the EGF receptor to the cytoskele-
ton suggest that modulation of the cytoskeleton may be involved in 
induction of migration by this growth factor [37]. 
EGF, TGF-a, and IGF-I are very likely present at the wound site 
and may be involved in normal wound repair [4 -9]. It is intriguing 
that in vitro these factors induce both migration and proliferation, 
which are the two crucial aspects of the epithelial response to cutane-
ous wounding. Why these processes should be under the apparently 
redundant control of several growth factors is not understood. To 
appreciate the specific functions of these diverse growth factors 
present at the wound site remains a challenge, with therapeutic 
potential in wound management. 
This lVork lVas supported by NIH grall t AR-39674-sub-06. 
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